Search - tctmd.com

Displaying 321 - 340 of 3886

Sort: Relevancy | Date

Presentation TCT 2024

TCT 705: Comparative Outcomes of Endovascular Intervention Versus Bypass Surgery for Peripheral Artery Disease in Patients With Atrial Fibrillation: A Retrospective Analysis of the National Inpatient Sample

Presenter: Olayiwola Bolaji

October 30, 2024

Presentation TCT 2024

TCT 704: The Safety and Efficacy of Utilizing Auryon Laser Atherectomy via Radial Artery Approach in Infrainguinal Arterial Disease (Sailor Registry)

Presenter: Rahul Sawney

October 30, 2024

Presentation TCT 2024

TCT 702: Shockwave Intravascular Lithotripsy in Calcified Common Femoral Lesions in Patients With Peripheral Arterial Disease: 30-Day Health Status Outcomes From CRUSH-PAD Trial

Presenter: Kim Smolderen

October 30, 2024

Presentation TCT 2024

TCT 611: Automatic Echocardiography Prompts Reveal Lack of Equitable Access to Care in Patients With Mitral Regurgitation: The Equitable Access Study II

Presenter: Sophie Offen

October 30, 2024

Presentation TCT 2024

TCT 588: Endovascular Cooling Catheter-Related Thrombosis: Impact on Clinical Outcomes

Presenter: Morgane Laverdure

October 30, 2024

Presentation TCT 2024

TCT 586: First-in-Human Experience With the Percutaneous Synchronized Cardiac Assist (PSCA) System: Extravascular Mechanical Circulatory Support

Presenter: Petr Neuzil

October 30, 2024

Presentation TCT 2024

TCT 585: Impella CP and 5.5 Device Flows Are Overestimated by the SmartAssist Automated Impella Controller (AIC)

Presenter: Christian Said

October 30, 2024

Presentation TCT 2024

TCT 584: Extracorporeal Versus Conventional Cardiopulmonary Resuscitation for Out-of-Hospital Cardiac Arrests: A Systematic Review and Meta-Analysis

Presenter: Tara Seirafi

October 30, 2024

Presentation TCT 2024

TCT 583: Influence of Heparin-Induced Thrombocytopenia on In-Hospital Outcomes in Patients With Left Ventricular Assist Devices (LVAD): A Decade-Long Study

Presenter: Neethi Dasu

October 30, 2024

Presentation TCT 2024

TCT 330: Outcomes of Percutaneous Coronary Intervention in Patients With Autosomal Dominant Polycystic Kidney Disease: National Inpatient Sample 2016-2021

Presenter: Daniel Hanna

October 30, 2024

Presentation TCT 2024

TCT 329: Pharmacokinetics of 14C-Labeled Zalunfiban (RUC-4) Suggests That No Dose Adjustment Is Necessary for Impaired Renal Function

Presenter: Sem Rikken

October 30, 2024

Presentation TCT 2024

TCT 328: Race, Percutaneous Coronary Interventions Outcomes for ST-Elevated Myocardial Infarction, and Chronic Kidney Disease: A Propensity Matched National Database Study

Presenter: Salman Abdul Basit

October 30, 2024

Presentation TCT 2024

TCT 327: Efficacy of High-Dose Statins on the Prevention of Contrast-Induced Nephropathy After Cardiac Catheterization: Updated Systematic Review and Meta-Analysis

Presenter: Montaser Elkholy

October 30, 2024

Presentation TCT 2024

TCT 326: Outcomes of Acute Kidney Injury and Hemodialysis Use in Acute Pulmonary Embolism

Presenter: Aryan Mehta

October 30, 2024

Presentation TCT 2024

TCT 325: Safety and Efficacy of Ultra-Low or Zero-Contrast IVUS-Guided Percutaneous Coronary Intervention in Advance Chronic Kidney Disease Patients

Presenter: Eunice Chuah

October 30, 2024

Presentation TCT 2024

Lessons Learned From Recent Clinical Trials (EARLY TAVR and AVATAR)

Presenter: Allan Schwartz

October 30, 2024

Presentation TCT 2024

Can “At Risk” Disease Phenotypes Prioritize Earlier Treatment (EVOLVED)

Presenter: Mark Dweck

October 30, 2024

Presentation TCT 2024

Debate Pro: Always

Presenter: Marco Valgimigli

October 30, 2024

Presentation TCT 2024

Debate Con: Never

Presenter: Dominick Angiolillo

October 30, 2024

Presentation TCT 2024

Transcatheter Mitral Valve Replacement in the Next Decade: From Current Trends to Futuristic Predictions

Presenter: Juan Granada

October 30, 2024

Advertisement

TCT 705: Comparative Outcomes of Endovascular Intervention Versus Bypass Surgery for Peripheral Artery Disease in Patients With Atrial Fibrillation: A Retrospective Analysis of the National Inpatient Sample

TCT 704: The Safety and Efficacy of Utilizing Auryon Laser Atherectomy via Radial Artery Approach in Infrainguinal Arterial Disease (Sailor Registry)

TCT 702: Shockwave Intravascular Lithotripsy in Calcified Common Femoral Lesions in Patients With Peripheral Arterial Disease: 30-Day Health Status Outcomes From CRUSH-PAD Trial

TCT 611: Automatic Echocardiography Prompts Reveal Lack of Equitable Access to Care in Patients With Mitral Regurgitation: The Equitable Access Study II

TCT 588: Endovascular Cooling Catheter-Related Thrombosis: Impact on Clinical Outcomes

TCT 586: First-in-Human Experience With the Percutaneous Synchronized Cardiac Assist (PSCA) System: Extravascular Mechanical Circulatory Support

TCT 585: Impella CP and 5.5 Device Flows Are Overestimated by the SmartAssist Automated Impella Controller (AIC)

TCT 584: Extracorporeal Versus Conventional Cardiopulmonary Resuscitation for Out-of-Hospital Cardiac Arrests: A Systematic Review and Meta-Analysis

TCT 583: Influence of Heparin-Induced Thrombocytopenia on In-Hospital Outcomes in Patients With Left Ventricular Assist Devices (LVAD): A Decade-Long Study

TCT 330: Outcomes of Percutaneous Coronary Intervention in Patients With Autosomal Dominant Polycystic Kidney Disease: National Inpatient Sample 2016-2021

TCT 329: Pharmacokinetics of 14C-Labeled Zalunfiban (RUC-4) Suggests That No Dose Adjustment Is Necessary for Impaired Renal Function

TCT 328: Race, Percutaneous Coronary Interventions Outcomes for ST-Elevated Myocardial Infarction, and Chronic Kidney Disease: A Propensity Matched National Database Study

TCT 327: Efficacy of High-Dose Statins on the Prevention of Contrast-Induced Nephropathy After Cardiac Catheterization: Updated Systematic Review and Meta-Analysis

TCT 326: Outcomes of Acute Kidney Injury and Hemodialysis Use in Acute Pulmonary Embolism

TCT 325: Safety and Efficacy of Ultra-Low or Zero-Contrast IVUS-Guided Percutaneous Coronary Intervention in Advance Chronic Kidney Disease Patients

Lessons Learned From Recent Clinical Trials (EARLY TAVR and AVATAR)

Can “At Risk” Disease Phenotypes Prioritize Earlier Treatment (EVOLVED)

Debate Pro: Always

Debate Con: Never

Transcatheter Mitral Valve Replacement in the Next Decade: From Current Trends to Futuristic Predictions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content